ACE2-independent entry factors for SARS-CoV-2 infection and immune activation
mBio · 2026
DOI: 10.1128/mbio.01897-24 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift mBio, 2026. Verfasst von Yiyu Sun und 2 weiteren Autor:innen. Beteiligte Einrichtung: Rutgers School of Graduate Studies, Newark, New Jersey, USA. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme 2, SARS-CoV-2, Virus Internalization, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIDCR NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), remains a major public health threat, particularly in vulnerable populations. SARS-CoV-2 spike proteins interact with the human angiotensin-converting enzyme 2 (ACE2) receptor, together with accessory molecules that facilitate viral entry, through its spike receptor-binding domain (RBD). Although ACE2 is the primary receptor required for viral replication, its expression patterns do not fully correlate with viral distribution or tissue pathology. Moreover, SARS-CoV-2 has been shown to infect cells and tissues lacking detectable ACE2 expression. Viral entry via ACE2-independent pathways may also confer resistance to some monoclonal antibodies (Abs) targeting the spike RBD that block ACE2-mediated binding. These observations highlight the potential significance of ACE2-independent entry factors in SARS-CoV-2 infection, particularly in vaccinated individuals with Abs directed against ACE2-dependent viral entry. In this review, we discuss the emerging roles of ACE2-independent entry factors in SARS-CoV-2 infection and the immune responses. These factors include CD147, AXL, CD169/Siglec-1, CD209L, CD209, CLEC4G, ASGR1, LDLRAD3, TMEM30A, TMEM106B, transferrin receptor 1, GPR78, integrin α5β1, KREMEN1, LFA-1, and CD4. While ACE2 remains central to viral replication, ACE2-independent entry appears sufficient to elicit immune responses. Therefore, future investigations are warranted to elucidate the roles of ACE2-independent mechanisms in immune-mediated pathology and viral evolution, independent of immune pressure targeting ACE2-mediated entry in previously infected or vaccinated individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rutgers School of Graduate Studies, Newark, New Jersey, USA.
- Public Health Research Institute, Newark, New Jersey, USA.
- Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
- Center for Virus-Host Innate Immunity, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
ORCID-Profile: Yiyu Sun, Lok-Yin Roy Wong, Theresa L Chang
Förderung
- NIAID NIH HHS
- NIDCR NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institute of Dental and Craniofacial Research
Zitieren
APA
Sun, Y., Wong, L. Y. R., & Chang, T. L. (2026). ACE2-independent entry factors for SARS-CoV-2 infection and immune activation. mBio. https://doi.org/10.1128/mbio.01897-24
Vancouver
Sun Y, Wong LYR, Chang TL. ACE2-independent entry factors for SARS-CoV-2 infection and immune activation. mBio. 2026. doi:10.1128/mbio.01897-24
BibTeX
@article{Sun2026,
author = {Sun, Yiyu and Wong, Lok-Yin Roy and Chang, Theresa L},
title = {ACE2-independent entry factors for SARS-CoV-2 infection and immune activation},
journal = {mBio},
year = {2026},
doi = {10.1128/mbio.01897-24}
}
EUVIMED